KRAS and lung adenocarcinoma: CD47 and p-STAT3 protein levels were consistently upregulated, and miR-34a was downregulated in the lung adenocarcinoma samples compared with the paired normal controls, regardless of KRAS mutation status (Supplemental Figure 13, G–I).